Trial Profile
Effects of Ultra-long Acting Bronchodilator Therapy Assessed by Impulse Oscillometry in Smoking Asthmatics Taking Inhaled Corticosteroids
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2021
Price :
$35
*
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary) ; Olodaterol
- Indications Asthma
- Focus Therapeutic Use
- Acronyms MAN05
- 20 Jun 2019 Status changed from active, no longer recruiting to completed.
- 18 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 05 Jul 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.